Expanded Access of Pimavanserin for Patients With PD Psychosis
NCT02762591
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease Psychosis
Interventions
DRUG:
Pimavanserin tartrate
Sponsor
ACADIA Pharmaceuticals Inc.